An Individualized ESA Dosing Regimen for Hemodialysis Patients To Stabilize Hemoglobin Levels in a Target Range

摘要

We previously reported on a modeling project designed to determine erythropoietic stimulating agent (ESA) dosing regimens for hemodialysis patients, (Rogers, Gallaher, and Hocum). There, we describe the stages of model development, its implementation, and the results obtained.